ALS-associated mutations in charged multivesicular body protein 2B (CHMP2B) and spastic paraplegia-11 (SPG11) have been reported to deregulate endosomal trafficking towards degradation. Here, SPG11 is linked to amyotrophic lateral sclerosis.